China Home Healthcare Market

ID: MRFR/HC/43313-HCR

200 Pages

Rahul Gotadki

September 2025

China Home Healthcare Market Research Report By Product Outlook (Testing, Screening and Monitoring Products, Blood Glucose Monitors, Blood Pressure Monitors, Pulse Oximeters, Peak Flow Meters, Heart Rate Monitors, Fetal Monitoring Devices, HIV Test Kits, Home Sleep Testing Devices, Others), By Service Outlook (Skilled Nursing Services, Rehabilitation Therapy Services, Hospice and Palliative Care Services, Unskilled Care Services, Respiratory Therapy Services, Infusion Therapy Services, Others) and By Indication Outlook (Cardiovascular Disord...

China Home Healthcare Market Infographic

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Infographic

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

China Home Healthcare Market Summary

The China Home Healthcare market is poised for substantial growth, projected to reach 38.6 USD Billion by 2035 from 16.7 USD Billion in 2024.

Key Market Trends & Highlights

China Home Healthcare Key Trends and Highlights

The market is expected to grow from 16.7 USD Billion in 2024 to 38.6 USD Billion by 2035.
The compound annual growth rate (CAGR) for the period from 2025 to 2035 is estimated at 7.92%.
This growth trajectory indicates a robust expansion in the home healthcare sector within China.
Growing adoption of telehealth solutions due to an aging population is a major market driver.

China Home Healthcare Market

CAGR

7.92%

Market Size & Forecast

2024 Market Size	16.7 (USD Billion)
2035 Market Size	38.6 (USD Billion)
CAGR (2025-2035)	7.92%

Major Players

GE Healthcare, WeDoctor, Tianjin Medical Group, Baihe Medical, Lifesense, Xiaomi, China National Pharmaceutical Group, Beijing Aeonmed, Tianjin Mindray, Mindray, Philips, Haier Biomedical, Alibaba Health Information Technology, United Imaging Healthcare, Caimo Health

China Home Healthcare Market Trends

The China Home Healthcare Market is experiencing significant shifts driven by several key market drivers. One of the main drivers is the increasing aging population, as more individuals are seeking home healthcare services due to the government’s focus on promoting elder care at home. With the aging demographic in China, there is a growing demand for services that support chronic conditions and provide post-operative care, which enhances the importance of home healthcare.

Additionally, rising disposable incomes and changing societal norms are prompting families to invest in healthcare services for their loved ones, further propelling the market.Opportunities to be explored in the China Home Healthcare Market include the integration of technology, such as telemedicine and mobile health applications, which can facilitate remote monitoring and consultations. The government is encouraging the use of technological advancements in the healthcare sector to improve service delivery. Moreover, promoting healthcare insurance policies that cover home care services can further expand access to care for patients in need.

Recent trends in home healthcare reflect a shift toward patient-centered care, where services are tailored to individual needs, emphasizing convenience and comfort. Chinese urban families are increasingly valuing personalized care plans and support services, a trend that is evident in the rise of various home healthcare providers offering comprehensive service packages.Additionally, there is a notable increase in the collaboration between hospitals and home care agencies, enabling a more seamless transition from hospital to home, ensuring ongoing care for patients.

This cooperative approach is setting a new standard in the delivery of healthcare services in China, highlighting the evolving dynamics of the home healthcare market.

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Market Segment Insights

China Home Healthcare Market Segment Insights

Home Healthcare Market Product Insights

The China Home Healthcare Market is characterized by a diverse array of products designed to meet the growing demand for at-home care solutions. Within the landscape of testing, screening, and monitoring products, there is a pronounced emphasis on meeting both preventive and therapeutic needs of patients. Blood glucose monitors have become crucial for managing diabetes, especially as the prevalence of the disease continues to rise in China, reflecting the need for reliable at-home monitoring solutions. Moreover, blood pressure monitors are also significant cardiovascular health, as hypertension remains a pressing public health challenge in the region.

Additionally, pulse oximeters play a pivotal role in providing real-time monitoring of oxygen saturation levels, particularly critical for patients with respiratory issues, thereby improving the quality of care delivered at home.

Fetal monitoring devices have gained traction due to the increasing focus on maternal health, enabling expectant mothers to monitor the well-being of their unborn child proactively. Similarly, HIV test kits have emerged as an essential tool for early detection and management of the disease, contributing positively to public health initiatives aimed at reducing transmission rates in China. Home sleep testing devices reflect another growing trend, as sleep quality is increasingly recognized as vital to overall wellness, helping individuals manage sleep disorders effectively at home.

In addition, peak flow meters and heart rate monitors further highlight the importance of chronic disease management, enabling patients to take control of their health with tools that facilitate regular monitoring and prompt action as required. The extensive range of products within the China Home Healthcare Market segmentation, coupled with increasing health awareness and the aging population, is driving substantial growth and innovation in the market landscape, presenting numerous opportunities for development in the sector.

Home Healthcare Market Service Insights

The Service Outlook for the China Home Healthcare Market showcases a diverse range of services catering to the increasing demand for at-home healthcare solutions. Skilled Nursing Services continues to play a vital role by providing professional care to patients who require medical attention in a familiar environment. Rehabilitation Therapy Services are gaining traction as they address the needs of individuals recovering from surgeries or chronic illnesses, promoting independence and enhancing quality of life.

Hospice and Palliative Care Services are significant due to the aging population in China, offering compassionate support for end-of-life care while prioritizing comfort and dignity.Unskilled Care Services cater to various daily living activities, filling the gap for families who need assistance but not clinical care, thus ensuring patients remain in their homes. Respiratory Therapy Services address growing concerns related to chronic respiratory conditions, essential in a country with severe air quality challenges. Infusion Therapy Services also hold importance, particularly for patients requiring ongoing treatment for conditions such as cancer.

The diverse range of options within the China Home Healthcare Market is supported by government initiatives and an increasing focus on preventative care, thus driving market growth and enhancing patient access to health services in their homes.

Home Healthcare Market Indication Insights

The China Home Healthcare Market is witnessing significant growth across various indications, driven by the increasing burden of chronic diseases and a rising elderly population. Within the Indication Outlook, conditions such as cardiovascular disorders, diabetes, and respiratory diseases are particularly noteworthy, as they represent major health challenges in China's aging demographic. The focus on home healthcare solutions for these disorders not only offers convenience but also promotes better health outcomes by allowing patients to receive continuous care within the comfort of their homes.Pregnancy-related healthcare is gaining traction as well, with an increasing demand for maternal and prenatal care services.

Mobility disorders and hearing disorders also play a crucial role, as they encapsulate the need for rehabilitation and assistive technologies, addressing the daily living challenges faced by many in the aging population. Cancer and wound care are critical areas of interest, with advancements in palliative and post-operative care facilitating better management at home. Overall, the segmentation of the market emphasizes the importance of tailored healthcare solutions that cater to the diverse needs of patients across various indications, contributing to the overall development and transformation of the healthcare landscape in China.

Get more detailed insights about China Home Healthcare Market Research Report - Forecast to 2035

Request Free Sample

Key Players and Competitive Insights

The China Home Healthcare Market is experiencing significant growth due to an increasing aging population, rising chronic diseases, and a greater preference for at-home care solutions. The competitive landscape of this market is diverse, with various players offering a range of products and services aimed at improving patient outcomes and enhancing the efficiency of home care. Companies in this sector are leveraging technological advancements, including telehealth platforms and portable medical devices, to capture the growing demand for personalized healthcare solutions.

As healthcare policies evolve and the public’s perception of home healthcare changes, the competitive dynamics are shifting, prompting businesses to innovate and adapt their strategies for sustainability and growth.GE Healthcare has established a strong foothold in the China Home Healthcare Market by offering a robust portfolio of medical imaging and monitoring solutions tailored for home use. With its advanced technologies that improve diagnostic accuracy and patient management, GE Healthcare is well-positioned to address the evolving needs of healthcare providers and patients alike.

The company’s strengths lie in its commitment to research and development, enabling it to stay at the forefront of innovation. GE Healthcare also focuses on strategic partnerships and collaborations within the region to expand its market presence and enhance its service offerings, thus solidifying its competitive edge in a rapidly evolving market.WeDoctor has become a key player in the China Home Healthcare Market by providing an integrated platform that includes online medical consultations, chronic disease management programs, and personalized health services.

The company's strengths are amplified by its ability to connect patients with healthcare professionals through its digital platform, facilitating access to timely medical advice and support. WeDoctor's robust digital ecosystem includes partnerships with hospitals and clinics, allowing for effective service delivery across various healthcare needs. The company has also engaged in strategic mergers and acquisitions to broaden its capabilities and expand its market reach, enhancing its service portfolio to include innovative healthcare solutions tailored to the needs of the Chinese population.

This proactive approach not only strengthens its competitive stance but also contributes to improving the overall quality of home healthcare in China.

Key Companies in the China Home Healthcare Market market include

Industry Developments

The China Home Healthcare Market has witnessed significant developments recently, driven by an aging population and increasing chronic disease prevalence. In September 2023, GE Healthcare announced advancements in home health technologies aimed at enhancing remote patient monitoring capabilities. WeDoctor has expanded its telemedicine services, integrating AI for improved diagnostics, while Tianjin Medical Group has been enhancing its home-care training programs for healthcare professionals to address the growing demand for at-home services. Notably, in August 2023, Lifesense secured a partnership with Alibaba Health Information Technology to enhance digital health solutions, further solidifying their market presence.

Furthermore, in June 2023, Philips announced a strategic investment aimed at developing connected health platforms tailored for home use, reflecting the shift towards home-based healthcare. In regard to mergers and acquisitions, in July 2023, Mindray acquired a smaller technology firm specializing in remote monitoring, reinforcing its commitment to innovation. The market dynamics indicate accelerated growth, with reported valuations increasing due to ongoing investments and technological advancements from companies like Xiaomi, Haier Biomedical, and United Imaging Healthcare, shaping the future landscape of home healthcare in China.

Market Segmentation

Product Outlook

Skilled Nursing Services
Rehabilitation Therapy Services
Hospice and Palliative Care Services
Unskilled Care Services
Respiratory Therapy Services
Infusion Therapy Services
Others

Service Outlook

Cardiovascular Disorders and Hypertension
Diabetes
Respiratory Diseases
Pregnancy
Mobility Disorders
Hearing Disorders
Cancer
Wound Care
Other

Indication Outlook

Cardiovascular Disorders and Hypertension
Diabetes
Respiratory Diseases
Pregnancy
Mobility Disorders
Hearing Disorders
Cancer
Wound Care
Other

Report Scope

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	15.45(USD Billion)
MARKET SIZE 2024	16.67(USD Billion)
MARKET SIZE 2035	38.57(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	7.925% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	GE Healthcare, WeDoctor, Tianjin Medical Group, Baihe Medical, Lifesense, Xiaomi, China National Pharmaceutical Group, Beijing Aeonmed, Tianjin Mindray, Mindray, Philips, Haier Biomedical, Alibaba Health Information Technology, United Imaging Healthcare, Caimo Health
SEGMENTS COVERED	Product Outlook, Service Outlook, Indication Outlook
KEY MARKET OPPORTUNITIES	Aging population increasing demand, Rising chronic diseases prevalence, Technological advancements in healthcare, Growing preference for at-home care, Government support for healthcare services
KEY MARKET DYNAMICS	aging population , increasing chronic diseases , technological advancements , rising healthcare costs , preference for home care
COUNTRIES COVERED	China

FAQs

What is the expected market size of the China Home Healthcare Market by 2024?

The China Home Healthcare Market is anticipated to reach a value of 16.67 USD Billion by the year 2024.

What is the projected market size of the China Home Healthcare Market by 2035?

By 2035, the China Home Healthcare Market is expected to be valued at 38.57 USD Billion.

What is the expected CAGR for the China Home Healthcare Market from 2025 to 2035?

The projected compound annual growth rate (CAGR) for the China Home Healthcare Market from 2025 to 2035 is 7.925%.

Which product segment is expected to dominate the China Home Healthcare Market?

The Testing, Screening and Monitoring Products segment is projected to dominate, valued at 5.0 USD Billion in 2024 and 11.5 USD Billion in 2035.

Who are the key players in the China Home Healthcare Market?

Major players in the market include GE Healthcare, WeDoctor, Tianjin Medical Group, and Philips among others.

What is the market value of Blood Glucose Monitors in 2024?

Blood Glucose Monitors are valued at 3.5 USD Billion in the year 2024.

What is the expected market value for Blood Pressure Monitors by 2035?

The market value for Blood Pressure Monitors is expected to be 9.4 USD Billion by 2035.

What growth opportunities exist in the China Home Healthcare Market?

Ongoing technological advancements and an aging population present significant growth opportunities in this market.

How much is the Pulse Oximeters segment valued at in 2024?

The Pulse Oximeters segment is valued at 2.67 USD Billion in 2024.

What is the projected market size of Peak Flow Meters by 2035?

The expected market size for Peak Flow Meters is projected to reach 2.8 USD Billion by 2035.

China Home Healthcare Market Research Report - Forecast to 2035 Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027